A Nebraska judge sentenced a 19-year-old woman to 90 days in jail and two years of probation Thursday for burning and burying a fetus she allegedly aborted with the help of her mother, per multiple reports.
Why it matters: In the aftermath of the Supreme Court overturning Roe v. Wade, the case has been closely watched by abortion advocates, who have said it could be an indicator of what's to come as states increase restrictions on abortion access.
Despite what your social feeds say, rotting in bed all day probably won’t make you feel better, psychologists warn.
Why it matters: Staying in bed might make you feel worse than you already are, says Jennifer Taitz, clinical psychologist and author of the forthcoming book “Stress Resets: How to Soothe Your Body and Mind in Minutes.”
Nearly two years after Texas' six-week abortion ban went into effect, the state's infant mortalities spiked by over 10% in 2022, according to preliminary data obtained by CNN.
Why it matters: Texas' ban, which was the strictest in the U.S. at the time of its enactment, may be driving the increase in infant deaths by forcing people to carry nonviable pregnancies to term.
COVID relief funds helped almost 75% of U.S. hospitals post positive operating income during the height of the pandemic, according to a new analysis that questions if the federal aid was too generous or misdirected.
Why it matters: The findings counter the industry narrative that the pandemic left many facilities in the red and grappling with the surging costs of care amid supply chain and labor shortages.
Inflation may be cooling, but high medical costs could still make consumers pay more for Affordable Care Act health insurance in 2024.
Why it matters: President Biden has launched an offensive focused on lowering consumers' medical costs. Higher premiums for ACA marketplace plans could throw a wrench in the administration's messaging as Biden's re-election campaign takes off.
An effort to get the FDA to pull a widely used prescription drug monitoring software package off the market is stoking a broader debate over how much technology is influencing opioid prescribing.
Driving the news: The Center for U.S. Policy says Bamboo Health's NarxCare should be classified a medical device and subject to regulation, because of the way it helps doctors and other providers decide if a patient should get painkillers.
Medical marijuana ignited fiery debates over whether a once-off-limit substance could have positive health effects. But as the Food and Drug Administration advances research into psychedelics like LSD and magic mushrooms, there's little of the same pushback.
Why it matters: It's a sign of howformerly taboo compounds have gained a foothold in the health care market — and how the nation is reevaluating approaches to mental health and the addiction crisis.
Johnson & Johnson was ordered by a California jury on Tuesday to pay $18.8 million to a man who said in a lawsuit that he developed cancer due to exposure to its baby powder, per Reuters. J&J said it will appeal the decision.
Why it matters: J&J is seeking to settle lawsuits from cancer survivors and their families who allege the company's talc-based powder caused their illness while denying that this is the case.
